These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6294738)

  • 1. Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma.
    Levenson RM; Sauerbrunn BJ; Bates HR; Newman RD; Eddy JL; Ihde DC
    Radiology; 1983 Feb; 146(2):513-8. PubMed ID: 6294738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
    Pollen JJ; Witztum KF; Ashburn WL
    AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response.
    Levenson RM; Sauerbrunn BJ; Ihde DC; Bunn PA; Cohen MH; Minna JD
    AJR Am J Roentgenol; 1981 Jul; 137(1):31-5. PubMed ID: 6264774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer presenting with normal serum PSA levels and boney metastases treated with zoledronic acid.
    Mystakidou K; Katsouda E; Parpa E; Vlahos L
    J Pain Palliat Care Pharmacother; 2005; 19(3):41-5. PubMed ID: 16219610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Skeletal scintigraphy for the observation of course and treatment of carcinoma of the prostate ].
    Pabst HW; Langhammer H; Schmid L; Sintermann R
    Rofo; 1981 Jul; 135(1):44-9. PubMed ID: 6288532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
    Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bone scan as a tumour marker in prostatic carcinoma.
    Chisholm GD; Stone AR; Beynon LL; Merrick MV
    Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer.
    Schneider JA; Divgi CR; Scott AM; Macapinlac HA; Seidman AD; Goldsmith SJ; Larson SM
    J Nucl Med; 1994 Nov; 35(11):1748-52. PubMed ID: 7525900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone scintigraphy in plasma-cell myeloma. A prospective study of 70 patients.
    Bataille R; Chevalier J; Rossi M; Sany J
    Radiology; 1982 Dec; 145(3):801-4. PubMed ID: 6292996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic prostatic pulmonary nodules with normal bone image.
    Petras AF; Wollett FC
    J Nucl Med; 1983 Nov; 24(11):1026-7. PubMed ID: 6226768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m labeled agents for skeletal imaging.
    Thrall JH
    CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone scintigraphy with 99m Tc pyrophosphate in neurology].
    Oberson R
    Schweiz Med Wochenschr; 1975 Feb; 105(5):140-5. PubMed ID: 164688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of serial bone scans in assessing response of bone metastases to systemic treatment.
    Citrin DL; Hougen C; Zweibel W; Schlise S; Pruitt B; Ershler W; Davis TE; Harberg J; Cohen AI
    Cancer; 1981 Feb; 47(4):680-5. PubMed ID: 6261915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear bone imaging in metastatic cancer of the prostate.
    Pollen JJ; Gerber K; Ashburn WL; Schmidt JD
    Cancer; 1981 Jun; 47(11):2585-94. PubMed ID: 6266636
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative bone scan and bone metastases in prostatic cancer.
    Grob JC; Thiel J; Méthlin G; Wolf P; Bollack C
    Urol Int; 1985; 40(1):45-7. PubMed ID: 3156441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How significant are serial bone scans in monitoring advanced prostatic cancer?
    Tekgül S; Ozen H; Ozyavuz R; Bakkaloğlu M; Remzi D
    Int Urol Nephrol; 1995; 27(1):87-91. PubMed ID: 7615375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of skeletal scintigraphy for oncological practice].
    Kampmann H; Buchelt L
    Rontgenblatter; 1983 Oct; 36(10):342-51. PubMed ID: 6227979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The indications for and limitations of bone scintigraphy in osteogenic sarcoma: a review of 55 patients.
    McKillop JH; Etcubanas E; Goris ML
    Cancer; 1981 Sep; 48(5):1133-8. PubMed ID: 6268278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of routine followup bone scans after definitive therapy of localized prostatic cancer.
    Huben RP; Schellhammer PF
    J Urol; 1982 Sep; 128(3):510-2. PubMed ID: 6214643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radionuclide diagnosis and therapy of skeletal metastases of prostatic cancer].
    Schümichen C
    Radiologe; 1984 Jan; 24(1):13-8. PubMed ID: 6200897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.